Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: Role of severe neutropenia and mucositis

Clinical Infectious Diseases

Volumn 30, Issue 1, 2000, Pages 195-197

  Labarca, Jaime A ^a   Leber, Amy L ^a   Kern, Valerie L ^a   Territo, Mary C ^a   Brankovic, Liliana E ^a   Bruckner, David A ^a   Pegues, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEBRILE NEUTROPENIA; HUMAN; MUCOSA INFLAMMATION; PRIORITY JOURNAL; SEROLOGY; STENOTROPHOMONAS MALTOPHILIA; TOTAL PARENTERAL NUTRITION;

BACTEREMIA; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MOUTH MUCOSA; NEUTROPENIA; PARENTERAL NUTRITION, TOTAL; RISK FACTORS; STENOTROPHOMONAS; STOMATITIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033959644     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313591     Document Type: Article

References (11)

1. Kardhori N, Elting L, Wong E, Schable B, Bodey GP. Nosocomial infection due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis 1990; 12:997-1003.
2. Muder RR, Harris AP, Muller S, et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis 1996; 22:508-12.
3. Elting LS, Bodey G. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 1990; 69:296-306.
4. Elting LS, Kardhori N, Bodey GP, Fainstein V. Nosocomial infections caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol 1990; 11:134-8.
5. Victor M, Arpi M, Bruun B, Joønnson V, Hansen M. Xanthomonas maltophilia bacteremia in immunocompromised hematologic patients. Scand J Infect Dis 1994; 26:163-70.
6. Krcmery V, Pichna P, Oravcova E, et al. Stenotrophomonas maltophilia bacteraemia in cancer patients: report of 31 cases. J Hosp Infect 1996; 34: 75-7.
7. Kerr KG, Hawkey PM, Child JA, Norflok DR, Anderson AW. Pseudomonas maltophilia infections in neutropenic patients and the use of imipenem. Postgrad Med J 1990; 66:1090.
8. Van Couwenberghe CJ, Farver TB, Cohen SH. Risk factors associated with isolation of Stenotrophomonas (Xanthomanas) maltophilia in clinical specimens. Infect Control Hosp Epidemiol 1997; 18:316-21.
9. Carmeli Y, Samore MH. Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonos maltophilia: a historical cohort study. Clin Infect Dis 1997; 24: 1131-4.
10. Chachaty E, Castagna L, Massei B, et al. Outbreak of Stenotrophomonas maltophilia (S.m.) infections in neutropenic patients: role of water distribution in hospital [abstract K-74]. In: Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego, CA). Washington, DC: American Society for Microbiology, 1998: 522.
11. Verweij PE, Meis JFGM, Christmann V, et al. Nosocomial outbreak of colonization and infection with Stenotrophomonas maltophilia in preterm infants associated with contaminated tap water. Epidemiol Infect 1998; 120: 251-6.